Literature DB >> 7665222

Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer.

M Ebert1, M Yokoyama, H Friess, M S Kobrin, M W Büchler, M Korc.   

Abstract

Expression of platelet-derived growth factor (PDGF) and PDGF receptors was examined in cultured human pancreatic cancer cells, in the normal human pancreas and in pancreatic adenocarcinomas. mRNA transcripts encoding PDGF A and B chains, and PDGF receptor beta (PDGFR beta) were present in PANC-I and HPAF human pancreatic cancer cells. Transforming growth factor beta I (TGF-beta I), but not PDGF-AA or -BB, enhanced PDGF A and B chain mRNA levels in both cell lines. In the normal human pancreas PDGF A chain mRNA levels were relatively abundant, whereas PDGF B chain mRNA levels were not detected and PDGF receptor alpha (PDGFR alpha) and beta mRNA transcripts were present at low levels. PDGF immunoreactivity was present in islet cells, and PDGFR alpha was present in acinar cells, whereas PDGFR beta was present in acinar cells and in the connective tissue. In the pancreatic cancers, PDGF A chain mRNA transcripts were also abundant, and 6 of 13 samples exhibited the PDGF B chain mRNA transcript. In addition, there was a 7-fold increase in the levels of PDGFR alpha and PDGFR beta in the cancer samples by comparison with the normal pancreas. By immunohistochemistry, PDGF and both PDGF receptors were present in the cancer cells, and PDGFR beta was abundant in fibroblasts and endothelial cells within the connective tissue.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665222     DOI: 10.1002/ijc.2910620507

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  32 in total

1.  Overexpression of platelet-derived growth factor (PDGF) B chain and type beta PDGF receptor in human chronic pancreatitis.

Authors:  M Ebert; H U Kasper; S Hernberg; H Friess; M W Büchler; A Roessner; M Korc; P Malfertheiner
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

2.  Effector T lymphocyte subsets in human pancreatic cancer: detection of CD8+CD18+ cells and CD8+CD103+ cells by multi-epitope imaging.

Authors:  K Ademmer; M Ebert; F Müller-Ostermeyer; H Friess; M W Büchler; W Schubert; P Malfertheiner
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

3.  The non-receptor tyrosine kinase c-Src mediates the PDGF-induced association between Furin and pro-MT1-MMP in HPAC pancreatic cells.

Authors:  Chong Shi; Yongchao Ma; Hao Liu; Yuxiang Zhang; Zesheng Wang; Hongti Jia
Journal:  Mol Cell Biochem       Date:  2011-10-25       Impact factor: 3.396

4.  Genetic variants in the platelet-derived growth factor subunit B gene associated with pancreatic cancer risk.

Authors:  Bensong Duan; Jiangfeng Hu; Hongliang Liu; Yanru Wang; Hongyu Li; Shun Liu; Jichun Xie; Kouros Owzar; James Abbruzzese; Herbert Hurwitz; Hengjun Gao; Qingyi Wei
Journal:  Int J Cancer       Date:  2017-12-04       Impact factor: 7.396

5.  Kinome-wide siRNA screening identifies molecular targets mediating the sensitivity of pancreatic cancer cells to Aurora kinase inhibitors.

Authors:  Lifang Xie; Michelle Kassner; Ruben M Munoz; Qiang Q Que; Jeff Kiefer; Yu Zhao; Spyro Mousses; Hongwei H Yin; Daniel D Von Hoff; Haiyong Han
Journal:  Biochem Pharmacol       Date:  2011-11-15       Impact factor: 5.858

Review 6.  The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells.

Authors:  M R Moniri; L-J Dai; G L Warnock
Journal:  Cancer Gene Ther       Date:  2014-01-03       Impact factor: 5.987

Review 7.  Exploiting novel molecular targets in gastrointestinal cancers.

Authors:  Wen W Ma; Manuel Hidalgo
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

8.  Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells.

Authors:  Mariano Hurtado; Juan José Lozano; Elisabeth Castellanos; Luis A López-Fernández; Keith Harshman; Carlos Martínez-A; Angel R Ortiz; Timothy M Thomson; Rosanna Paciucci
Journal:  Gut       Date:  2007-04-23       Impact factor: 23.059

9.  High expression of heparanase is significantly associated with dedifferentiation and lymph node metastasis in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA and via HIF1a to HB-EGF and bFGF.

Authors:  Andreas-Claudius Hoffmann; Ryutaro Mori; Daniel Vallbohmer; Jan Brabender; Uta Drebber; Stephan E Baldus; Ellen Klein; Mizutomo Azuma; Ralf Metzger; Christina Hoffmann; Arnulf H Hoelscher; Kathleen D Danenberg; Klaus L Prenzel; Peter V Danenberg
Journal:  J Gastrointest Surg       Date:  2008-08-13       Impact factor: 3.452

10.  Small molecule tyrosine kinase inhibitors in pancreatic cancer.

Authors:  Sachin Gupta; Bassel F El-Rayes
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.